Cramer’s week ahead: Earnings season kicks off after JPMorgan Healthcare Conference
CNBC's Jim Cramer told investors to pay attention next week to the JPMorgan Healthcare Conference. Source link
Read More
Eli Lilly and Co
Eli Lilly’s direct drug sales alone may not upend the industry, but others could follow suit
LillyDirect is the latest attempt to simplify what critics call a complex system for distributing, pricing and prescribing prescription drugs.
Read More
Stocks making the biggest moves premarket: Walgreens, Apple, Yeti & more
Check out the companies making headlines in midday trading. Source link
Read More
Stocks making the biggest moves midday: Xerox, SoFi, Charles Schwab and more
These are the stocks posting the largest moves in midday trading. Source link
Read More
Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to watch
Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. A look at what 2024 might
Read More
Bristol Myers to buy RayzeBio for $4.1 billion in targeted cancer therapy push
Bristol Myers Squibb said on Tuesday it would buy RayzeBio for about $4.1 billion to bolster its cancer drug business.
Read More
Oprah’s flip on weight loss drugs is a sign of what’s to come for the ‘Ozempic trade’ in 2024
Oprah Winfrey has changed her mind on weight loss drugs and others have, too. What's ahead for the category in
Read More
Here are the big health sector themes to watch next year
The health-care sector has seen a big rebound this month, and analysts say some beaten-down names will continue to have
Read More
The weight loss drug boom isn’t over yet — here’s what to expect in the year ahead
2024 will be another big year for weight loss drugs, which soared in popularity despite hefty price tags, mixed insurance
Read More